FlyteHealth, a New Canaan, Connecticut-based early cardio-kidney-metabolic (eCKM) care platform, has been selected for the Diabetes and Obesity category within the Centers for Medicare and Medicaid Services (CMS) Health Tech Ecosystem, a curated directory of qualified digital health solutions available to Medicare Advantage organizations and other CMS-affiliated health plans.
The CMS Health Tech Ecosystem allows health plans to reference vetted technology and care partners when evaluating digital health solutions. FlyteHealth's listing recognizes the platform as a qualified patient-facing solution supporting individuals managing diabetes, obesity, and related cardio-kidney-metabolic conditions through integrated, artificial intelligence (AI)-enabled clinical care, personalized member engagement, and longitudinal support. FlyteHealth was also featured by CMS ahead of the Medicare ACCESS Model launch scheduled for July 1, highlighting the company's approach to eCKM care delivery.
The recognition builds on a body of validated outcome data. An independently validated analysis by Milliman found 86% adherence at 12 months and 16.6% average weight loss among FlyteHealth participants, alongside improvements in blood pressure, A1c, low-density lipoprotein (LDL) cholesterol, and other biometrics. A separate Segal Group report found that FlyteHealth generated nearly $30 million in pharmacy cost avoidance for the State of Connecticut.
"Medicare enrollees are at high risk for eCKM, with 70% having multiple chronic conditions. At FlyteHealth, we have managed members 65 and older since our founding and have published results of improved outcomes across measures of diabetes, obesity, and hypertension. That experience is unique to FlyteHealth," said Cheryl Pegus, MD, MPH, CEO of FlyteHealth. "Being included in the CMS Health Tech Ecosystem continues FlyteHealth's expansion in integrated cardio-kidney-metabolic care and reinforces our commitment to delivering accessible, patient-centered solutions across all populations and geographies."
FlyteHealth's platform serves employers, health plans, and provider organizations managing eCKM conditions including hypertension, hyperlipidemia, prediabetes, diabetes, cardiovascular disease, chronic kidney disease, and obesity. The CMS selection aligns with the agency's broader efforts to improve interoperability, expand patient access to digital health tools, and reduce administrative burden across healthcare settings.